🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

7,387 results for “Le” Clear

  1. Edaravone dexborneol

    The First People's Hospital of Lianyungang

    Acute Ischemic Stroke

    approved small molecule active

    1 trial

  2. Electronic Cigarette

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule active

    1 trial

  3. Eliquis 5 mg film-coated tablets, Waran 2,5 mg tabletter, OPTISON 0.19 mg/ml dispersion for injection, SonoVue 8 microlitres/mL powder and solvent for dispersion for injection, Eliquis 2.5 mg film-coated tablets

    The George Institute

    Left ventricular thrombosis., Acute mycocardial infarction (AMI)

    approved small molecule active

    1 trial

  4. Elucirem 0.5 mmol/mL solution for injection, Gadovist 1.0 mmol/ml solution for injection in prefilled cartridge

    The George Institute

    Perianal fistula associated with Crohn's disease

    approved small molecule active

    1 trial

  5. Enbrel 25 mg powder and solvent for solution for injection, ADALIMUMAB, ETANERCEPT, Humira 20 mg solution for injection in pre-filled syringe

    Fondazione Telethon ETS

    Juvenile Idiopathic Arthritis

    approved small molecule active

    1 trial

  6. Enema transplant of fecal microbiota, Placebo double encapsulated oral transplant of fecal microbiota, Placebo coloscopic transplant of Fecal microbiota, Double encapsulated oral transplant of fecal microbiota

    Pari Pharma GmbH

    Crohn’s disease

    approved small molecule active

    1 trial

  7. Entecavir+Fuzheng Huayu+TCM Granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Virus Related Cirrhosis

    approved small molecule active

    1 trial

  8. Epidiolex 100 mg/mL Oral Solution

    Jazz Pharmaceuticals Ireland Limited

    Dravet Syndrome (DS)

    approved small molecule active

    1 trial

  9. Epidyolex 100 mg/ml oral solution

    Lacuna Pharma Pty Ltd

    Tuberous Scerlosis Complex

    approved small molecule active

    1 trial

  10. Esketamine

    The First People's Hospital of Lianyungang

    Postpartum Depression

    approved small molecule active

    1 trial

  11. Esketamine

    The First People's Hospital of Lianyungang

    Scoliosis Correction

    approved small molecule active

    1 trial

  12. Esketamine 0.2 mg/kg

    The First People's Hospital of Lianyungang

    Cesarean Delivery

    approved small molecule completed

    1 trial

  13. Esketamine 1

    The First People's Hospital of Lianyungang

    Elderly

    approved small molecule active

    1 trial

  14. Esketamine combined with dexmedetomidine

    The First People's Hospital of Lianyungang

    Dexmedetomidine

    approved small molecule active

    2 trials

  15. Etomidate

    Hospital Authority, Hong Kong

    Choledocholithiasis

    approved small molecule completed

    1 trial

  16. Etoposide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mantle Cell Lymphoma

    approved small molecule completed

    1 trial

  17. Eufilina Venosa 200 mg solución inyectable, Clariscan 0,5 mmol/mL solución inyectable EFG, Rapiscan 400 microgram solution for injection

    The George Institute

    Coronary artery chronic total occlusion

    approved small molecule active

    1 trial

  18. Exenatide

    The First People's Hospital of Lianyungang

    Type 2 Diabetes

    approved small molecule active

    1 trial

  19. Exparel

    Pacira Ireland Limited

    Ankle Arthrodesis

    approved small molecule completed

    1 trial

  20. Experimental 23-valent PPV

    Sinovac Research and Development Co.,

    Pneumococcal Infections

    approved mab completed

    1 trial

  21. Experimental 23-valent Pneumococcal

    Sinovac Research and Development Co.,

    Pneumococcal Infections

    approved mab completed

    1 trial

  22. Extended-Release Buprenorphine (XRB)

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule active

    1 trial

  23. Extended-Release Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    approved small molecule completed

    1 trial

  24. Eylea (Intravitreal Aflibercept, VEGF Trap-Eye, BAY86-5321)

    Regeneron UK Limited

    Macular Degeneration

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources